幽门螺杆菌在胃癌发生中的作用机制。
Helicobacter pylori in gastric carcinogenesis: mechanisms.
机构信息
Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.
出版信息
Gastroenterol Clin North Am. 2013 Jun;42(2):285-98. doi: 10.1016/j.gtc.2013.01.006. Epub 2013 Mar 6.
Abstract
Helicobacter pylori infection induces chronic inflammation and is the strongest known risk factor for gastric cancer. The genomes of H pylori are highly diverse and therefore bacterial virulence factors play an important role in determining the outcome of H pylori infection, in combination with host responses that are augmented by environmental and dietary risk factors. It is important to gain further understanding of the pathogenesis of H pylori infection to develop more effective treatments for this common but deadly malignancy. This review focuses on the specific mechanisms used by H pylori to drive gastric carcinogenesis.
摘要
幽门螺杆菌感染会引起慢性炎症，是已知的最强胃癌风险因素。幽门螺杆菌的基因组高度多样化，因此细菌的毒力因子在确定幽门螺杆菌感染的结果方面起着重要作用，这与宿主反应相结合，宿主反应会受到环境和饮食风险因素的增强。深入了解幽门螺杆菌感染的发病机制对于开发针对这种常见但致命恶性肿瘤的更有效治疗方法非常重要。本文综述重点关注了幽门螺杆菌用于驱动胃癌发生的特定机制。
相似文献
1
Helicobacter pylori in gastric carcinogenesis: mechanisms.幽门螺杆菌在胃癌发生中的作用机制。
Gastroenterol Clin North Am. 2013 Jun;42(2):285-98. doi: 10.1016/j.gtc.2013.01.006. Epub 2013 Mar 6.
2
Helicobacter pylori virulence factors in gastric carcinogenesis.幽门螺杆菌在胃癌发生中的毒力因子
Cancer Lett. 2009 Sep 8;282(1):1-8. doi: 10.1016/j.canlet.2008.11.016. Epub 2008 Dec 25.
3
Helicobacter and gastric malignancies.幽门螺杆菌与胃部恶性肿瘤
Helicobacter. 2008 Oct;13 Suppl 1(Suppl 1):28-34. doi: 10.1111/j.1523-5378.2008.00633.x.
4
Host pathogen interactions in related gastric cancer.相关胃癌中的宿主-病原体相互作用
World J Gastroenterol. 2017 Mar 7;23(9):1521-1540. doi: 10.3748/wjg.v23.i9.1521.
5
Helicobacter pylori virulence and cancer pathogenesis.幽门螺杆菌的毒力与癌症发病机制。
Future Oncol. 2014 Jun;10(8):1487-500. doi: 10.2217/fon.14.29.
6
Role of TNF-α-Inducing Protein Secreted by as a Tumor Promoter in Gastric Cancer and Emerging Preventive Strategies.由[具体内容未给出]分泌的肿瘤坏死因子-α诱导蛋白作为胃癌肿瘤促进因子的作用及新出现的预防策略。
Toxins (Basel). 2021 Mar 1;13(3):181. doi: 10.3390/toxins13030181.
7
Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer.幽门螺杆菌相关胃癌的分子发病机制
Gastroenterol Clin North Am. 2015 Sep;44(3):625-38. doi: 10.1016/j.gtc.2015.05.011. Epub 2015 Jul 7.
8
FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370.FoxM1 在幽门螺杆菌诱导的胃癌发生中过表达，并受 miR-370 的负调控。
Mol Cancer Res. 2013 Aug;11(8):834-44. doi: 10.1158/1541-7786.MCR-13-0007. Epub 2013 Apr 10.
9
Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.幽门螺杆菌毒力因子CagA通过多种信号通路促进胃癌的肿瘤发生。
Cell Commun Signal. 2015 Jul 11;13:30. doi: 10.1186/s12964-015-0111-0.
10
Immunostimulatory membrane proteins potentiate -induced carcinogenesis by enabling CagA translocation.免疫刺激膜蛋白通过促进 CagA 易位增强 - 诱导的致癌作用。
Gut Microbes. 2021 Jan-Dec;13(1):1-13. doi: 10.1080/19490976.2020.1862613.
引用本文的文献
1
: Unraveling its potential role in gastric carcinogenesis.: 揭示其在胃癌发生中的潜在作用。
World J Gastroenterol. 2024 Sep 21;30(35):3972-3984. doi: 10.3748/wjg.v30.i35.3972.
2
Role of Helicobacter pylori virulence factors and alteration of the Tumor Immune Microenvironment: challenges and opportunities for Cancer Immunotherapy.幽门螺杆菌毒力因子的作用与肿瘤免疫微环境的改变：癌症免疫治疗面临的挑战与机遇
Arch Microbiol. 2024 Mar 15;206(4):167. doi: 10.1007/s00203-024-03908-6.
3
Cross-talk between and gastric cancer: a scientometric analysis.和胃癌之间的串扰：一项科学计量学分析。
Front Cell Infect Microbiol. 2024 Jan 31;14:1353094. doi: 10.3389/fcimb.2024.1353094. eCollection 2024.
4
Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update.用于抗癌药物递送治疗的天然高分子纳米生物复合材料：最新进展
Pharmaceutics. 2023 Jul 31;15(8):2064. doi: 10.3390/pharmaceutics15082064.
5
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.靶向癌症特异性代谢途径以开发新型癌症治疗方法。
Front Immunol. 2022 Dec 22;13:955476. doi: 10.3389/fimmu.2022.955476. eCollection 2022.
6
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.胃癌肿瘤微环境代谢重编程在免疫治疗中的作用及机制。
Cell Death Dis. 2022 Apr 20;13(4):378. doi: 10.1038/s41419-022-04821-w.
7
Spot-light on microbiota in obesity and cancer.聚焦肥胖与癌症中的微生物组。
Int J Obes (Lond). 2021 Nov;45(11):2291-2299. doi: 10.1038/s41366-021-00866-7. Epub 2021 Aug 6.
8
Infection in Tripoli, North Lebanon: Assessment and Risk Factors.黎巴嫩北部的黎波里的感染情况：评估与风险因素。
Biology (Basel). 2021 Jun 28;10(7):599. doi: 10.3390/biology10070599.
9
The Clinicopathological Features and Genetic Alterations in Epstein-Barr Virus-Associated Gastric Cancer Patients after Curative Surgery.根治性手术后爱泼斯坦-巴尔病毒相关胃癌患者的临床病理特征及基因改变
Cancers (Basel). 2020 Jun 10;12(6):1517. doi: 10.3390/cancers12061517.
10
Helicobacter pylori-related risk predictors of gastric cancer: The latest models, challenges, and future prospects.幽门螺杆菌相关胃癌风险预测因子：最新模型、挑战与未来展望。
Cancer Med. 2020 Jul;9(13):4808-4822. doi: 10.1002/cam4.3068. Epub 2020 May 4.
本文引用的文献
1
Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans.缺铁加速了幽门螺杆菌在啮齿动物和人类中的致癌作用。
J Clin Invest. 2013 Jan;123(1):479-92. doi: 10.1172/JCI64373. Epub 2012 Dec 21.
2
Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells.活性氧诱导的幽门螺杆菌 CagA 自噬降解在肿瘤干细胞样细胞中被特异性抑制。
Cell Host Microbe. 2012 Dec 13;12(6):764-77. doi: 10.1016/j.chom.2012.10.014.
3
Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses.致病细菌幽门螺杆菌改变了 p53 蛋白异构体的表达谱，并改变了 p53 对细胞应激的反应。
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):E2543-50. doi: 10.1073/pnas.1205664109. Epub 2012 Aug 27.
4
Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin.幽门螺杆菌致癌蛋白 CagA 与β1 整合素相互作用的结构见解。
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14640-5. doi: 10.1073/pnas.1206098109. Epub 2012 Aug 20.
5
Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.白细胞介素-32 在幽门螺杆菌诱导的胃炎症中的作用。
Infect Immun. 2012 Nov;80(11):3795-803. doi: 10.1128/IAI.00637-12. Epub 2012 Aug 13.
6
Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA.三级结构-功能分析揭示了幽门螺杆菌致癌效应因子 CagA 的致病信号增强机制。
Cell Host Microbe. 2012 Jul 19;12(1):20-33. doi: 10.1016/j.chom.2012.05.010.
7
Relationship of IL-1 and TNF-α polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population.IL-1 和 TNF-α 多态性与巴西人群胃疾病中幽门螺杆菌的关系。
Braz J Med Biol Res. 2012 Sep;45(9):811-7. doi: 10.1590/s0100-879x2012007500099. Epub 2012 Jun 21.
8
Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression.分析盐诱导上调 CagA 表达所需的幽门螺杆菌 cagA 启动子元件。
Infect Immun. 2012 Sep;80(9):3094-106. doi: 10.1128/IAI.00232-12. Epub 2012 Jun 18.
9
c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains.c-Src 和 c-Abl 激酶控制西方和东亚幽门螺杆菌菌株中 CagA 效应蛋白的层次磷酸化和功能。
J Clin Invest. 2012 Apr;122(4):1553-66. doi: 10.1172/JCI61143. Epub 2012 Mar 1.
10
The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma.幽门螺杆菌 CagA EPIYA C 酪氨酸磷酸化基序的数量影响胃炎的模式和胃癌的发展。
Histopathology. 2012 May;60(6):992-8. doi: 10.1111/j.1365-2559.2012.04190.x. Epub 2012 Feb 20.
Zotero 插件